Blue Horseshoe Stocks: Several Key Updates

Intercloud Systems, Inc. ICLD

In yesterday’s report kicking off the new trading week, we backtracked to our alert of ICLD coming in our report from two Thursday’s ago, at which time the stock was trading at a low of .0157.

We mentioned how it had risen exponentially since that report, and specifically cautioned our readers to track its movements closely right from yesterday’s opening bell. The strength of the ICLD close on Friday was simply too strong to ignore and despite already having spiked considerably for us up to that point, the stock turned in another fantastic intraday performance.

From an early low of .05, the stock ran all the way to .0869 during the course of a session where it steadily climbed all day long and closed near its high. That marked an intraday boost of 74% and and an overall move up of 340% from our observed low from Thursday the 2nd,

Once again, with the intensely bullish close to another session, we’re going to have our eyes peeled for further moves from ICLD, whether they come in the form of a continued push upward, or are preceded by a dip-and-rip pattern off of these impressive highs.


Ciber, Inc. CBR

Prior to yesterday, CBR had been stuck in a rut for quite some time, but we noticed some abnormal premarket activity and decided to include it in yesterday’s report. It was a good idea, with CBR running from .4329 to .65, which works out to a 50% intraday pop.

The move came in conjunction with the company announcement that it was mulling over an unsolicited offer to be acquired through merger by Ameri Holdings, Inc. (AMRH) which values it at .75/share of CBR stock.

Given that the stock is still trading in the low .60′s at present, we’ll be interested to continue to monitor its progress as the company deliberates the merger offer.


More Key Updates

Cerulean Pharmaceuticals, Inc. CERU - We began tracking CERU just over a month ago, and after an extended period of slow and steady increases, finally yesterday the stock broke out in a more significant manner.

Our initial alert on CERU came on the 3rd of February, at which time the stock was trading at a low of 1.11. Yesterday the stock streaked to an impressive new high of 2.65, which comes out to a total upswing of 139%

______

Aurinia Pharmaceuticals, Inc. AUPH -  AUPH is another stock we’ve been tracking for much of 2017 so far that also broke to new highs yesterday. We witnessed a low of 2.95 in AUPH subsequent to our alert on the stock dated January 27th. Gradual increases over the next month would occur, and since we’ve hit the month of March, the stock has been going haywire.

Yesterday AUPH soared to (and closed at) 10.54 which represents a total move of 257% in less than six weeks!


Fresh Options Idea
Direxion Daily Jr Gld Mnrs Bull 3X ETF  – JNUG 03/31 $7-8 Calls


Extended Watchlist:
MGI, CPRX, GALT, EARS, RNN

Incoming search terms:

  • icld premarket

Blue Horseshoe Stocks: AA Options Update & More

Alcoa, Inc. AA – Options Idea

We took the opportunity to target some AA puts yesterday morning after noticing a technically weak chart, combined with a let-down on the company’s earnings report. Post-earnings options ideas are quite simply one of our favorite ways to see rapid moves to the upside, and Alcoa was no exception to that rule.

Our specific targets were the AA Weekly $32-30 Puts, and every set of contracts within that range afforded us the chance at hefty single-session profits.

$32 Puts – Range: 2.64-3.77 – Max Gain: 43%
$31.50 Puts – Range: 1.93-3.59 – Max Gain: 86%
$31 Puts – Range: 1.57-3.98 – Max Gain: 153%
$30.50 Puts – Range: 1.16-2.58 – Max Gain: 122%
$30 Puts – Range: .65-2.11 – Max Gain: 225%

With the stock gapping down slightly in the premarket once again, we’ll be on the lookout for those ranges to be extended. Should the stock’s heavy decline continue, we’ll continue to track those, as well as explore the possibility of rolling down our strike prices to stay closer to the money.


BioStar Pharmaceuticals, Inc. BSPM

We want to circle back around to provide an update on the recent activity of BSPM, which we placed on watch back on the 15th of last month. We would subsequently observe a low of 2.54 the following morning, and after a steady stair-stepping performance in ensuing sessions, the stock went meteoric during trading yesterday.

It made an excellent 96% intraday push from 3.60 up to its new high of 7.06, which marked an overall increase of 178% above the low we witnessed just under a month ago. The move was catalyzed by the launch of the company’s rhinitis and sinusitis treatment in China; an absolutely huge market.


Extended-Term Options Ideas

We want to signal some longer-term options ideas for tracking in the weeks ahead on both Nike and Lululemon. NKE just registered new 52-week lows yesterday, while LULU has come down its lowest PPS since February. Therefore, we’d like to monitor the activity in the following options contracts.

Nike, Inc. NKE – 12/16 $50-57.50 Calls

Lululemon Athletica, Inc. LULU – 12/08 $55-62.50 Calls


Extended Watchlist:
AMMJ, ICBU, TNRG, RNN, CUDA

Blue Horseshoe Stocks: CNDO Recap & Much More

Esperion Therapeutics, Inc. ESPR

ESPR was an unstoppable juggernaut for us this week. On Tuesday, we floated the idea of tracking the ESPR 04/17 $90 Calls, and those contracts have gone on a wild run since then.

As the stock pushed its way to new 52-week highs yesterday, finally topped those contracts out at 28.50, it marked an overall increase of 714% from the 3.50 low we observed on Tuesday; quite an impressive feat for a span of just three sessions.

Add in the multiplicity of opportunities in short-term weekly calls that we’ve witnessed (on the order of percentage gains in the thousands!) as the stock made this historical run, and we’ll have to mark ESPR down as one of our most successful alerts thus far in 2015.


Coronado BioSciences, Inc. CNDO

CNDO did quite well following our tag of it in yesterday morning’s extended watchlist, further solidifying the notion that biopharmas have been on a real hot streak this week.

We watched as CNDO ripped its way from a daily low of 3.62 to as high as 5.35, totaling an intraday run of 48% The move came on volume which smashed the 3-month average by a factor of more than 32X Congrats to any of our readers who lassoed this momentum-mover for some tidy gains yesterday!


Amicus Therapeutics, Inc. FOLD

FOLD also appear on yesterday’s watchlist before extending its own epic run with a modest yet notable increase of 13% on the day, trading a range from 11.63-13.20. Like the previously mentioned play, this stock has also been on a blue-sky breakout, setting new annual highs with every uptick.


Morning Gappers – Options Ideas

Nike, Inc. NKE shares surged as the company beat Wall St. estimates for profits on yesterday’s earnings call, and appears to be gapping up significantly in this morning’s premaket activity. We are going to be monitoring the $101-104 Weekly Calls for potential daytrading opportunities, and for a possible a swing trade into the weeks ahead, we’ll radar the 04/10 $105-110 Calls.

Prothena Corp plc PRTA is gapping up monstrously today to the tune of 40%, soaring on yesterday’s post-market revelation of positive Phase 1 results for its treatment for Parkinson’s disease. We will be placing $35 and 40 Calls on watch for daytrading potential, while tracking the 06/19 $45 Calls for a longer-term play.


Extended Watchlist:
VBLT, SPEX, VGGL, ICLD, RNN

Blue Horseshoe Stocks: NQ Review & More

NQ Mobile, Inc.  NQ

Our coverage of NQ stretches all the way back to the Fall of 2013 when the stock made a huge run, and we tracked it to a similar albeit smaller-scale spike in October, so we are quite familiar with this play. We have good reason to re-assess NQ this morning in the wake of an interesting PR, coupled with a good positioning of the chart.

In terms of the NQ chart, there a couple of finer points that we’ll point out on the following snapshot:

This morning’s PR relates to a big open market stock repurchase by management which seems to be fueling NQ in the premarket. >>> VIEW PR  



Cannabis Coverage:

A few of the marijuana-related stocks we were mentioning yesterday morning managed to put up some solid numbers over the course of the day.

CBIS traded in a range from .068-.08 (+17%) on roughly 4X its monthly average volume.

MCIG did slightly better as recorded a 19% move from .15 to .178, trading more than twice its average volume.

EAPH
also had a heavy volume day to the tune of roughly 3X its average, and made a healthy jump of 21% as it traded from its open at .024 to a high of .029.

As medical and recreational marijuana acceptance continues to spread, we’ll need to keep a close eye on these and many other cannabis plays, as we tend to believe that growth in this arena will be more substantial in 2015 than any previous year.

A few other pot plays to watch this week: WDHR, NRTI, MDCN, LATF, VPOR


Extended Watchlist:
CYTR, NERV, FRO, CPST, DARA, MNK, SNSS, RNN

Blue Horseshoe Stocks: LPCN Recap, LPDX & More

Lipocine, Inc. LPCN

LPCN served up an opportunity at some decent intraday gains after appearing on yesterday morning’s extended watchlist.

The stock played out a classic dip and rip scenario, falling to a morning low of 6.89 before surging back in the afternoon to a subsequent high of 8.42. That offered traders a chance at intraday gains of up to 22% on plenty of liquidity- the stock would trade 23.5X its 30-day average volume.

The productive session came on the heels of the company announcing favorable results from Phase-3 clinical testing of “LPCN 1021″, its oral treatment for low testosterone >>> VIEW PR


LipoScience, Inc. LPDX

LPDX is gapping up heavily in the premarket, and the interesting story behind it is one that we’re definitely going to want to give our close attention. Early this morning, the company announced that it was the subject of a buyout that would be executed at a share price of $5.25. Barely an hour later, another PR hit the LPDX newswire, concerning an investigation of the managerial board’s handling of the deal, and whether or not they have secured the best possible buyout price.

According to the investigative firm leading the case, “The $5.25 per share acquisition price is far less than where the stock has recently traded. In fact, on January 25, 2013, LipoScience stock opened for trading at $9.75 the day the Company sold 5.0 million shares of stock in its initial public stock offering.” >>> VIEW PR

The playing out of this scenario is going to be an interesting story moving forward, which is why we wanted to flag LPDX this morning, and fill everyone in on this morning’s happenings. The possibility that the investigation could lead to a potential restructuring of the buyout is enough to have us keep our ears to the tracks on this one for the foreseeable future.


Magnum Hunter Resources Corp. MHR

MHR is another morning gapper that we’re putting on our radars. This morning Magnum announced impressive throughput volumes on its “Eureka Hunter” gas gathering pipeline. According to the CEO, “increased capacity has resulted in a record day of approximately 316,500 MMBtu of natural gas”. >>> VIEW PR


Options Trading Idea: PBR Calls 

We’re interested in the PBR October 31st $15.50 Calls  last traded at 1.88. If we can see PBR make its way back to recent $20+ highs within a month, it could put us in position to see returns of up to 150-200% on those contracts.


Extended Watchlist:
 RNN, MNKD, CNET, VHC, MPET